Tokyo, June 2 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000055262) titled 'Investigating the changes in various clinical parameters induced by tirzepatide' on June 1

Study Type:

Observational

Study Design:

Primary Sponser:

Institute - Shinmatsudo Central General Hospital

Condition:

Condition - type 2 diabetes Classification by malignancy - Others Genomic information - NO

Objective:

Intervention:

Eligibility:

Age-lower limit - 20 years-old = Gender - Male and Female Key inclusion criteria - Patients were adults aged 20 years or older, diagnosed with type 2 diabetes, who could regularly attend our hospital, with HbA1c below 10.0% and BMI of 23 kg/m2 or higher. Key exclusion criteria...